Literature DB >> 22252752

The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.

Katarzyna Starska1, Ewa Głowacka, Andrzej Kulig, Iwona Lewy-Trenda, Magdalena Bryś, Przemysław Lewkowicz.   

Abstract

The role of interactions between tumor cells and autologous immunocompetent cells, the impact on the modulation of the activity of T CD4(+) and CD8(+) lymphocytes, as well as the influence on the regulation and determination of antitumor cellular immune response in patients with head and neck squamous cell carcinomas (HNSCC) is not completely clear. The aim of this study was to analyze early and late activation antigens expression on T cells subpopulations modified under the influence of the presence of cancer cells to investigate the regulatory mechanisms of the local cellular immune response in carcinoma of the larynx. Cytofluorymetric analysis of the early (CD69(+), CD71(+)) and late activation markers (CD25(+) (high), CD26(+), HLA/DR(+)) expression on T CD3(+)CD4(+) and CD3(+)CD8(+) cells subpopulations in mixed cellular cultures of freshly isolated tumor cells (MLTMC) and non-cancerous normal epithelial cells (MLNCC) with immunocompetent cells was performed in 55 cases of squamous cell laryngeal carcinoma. The whole peripheral blood concentrations of IL-10 and IFN-γ in 21 h and 72 h of experiments were also measured by ELISA. The relationships between the activation markers expression depending on the type of cells used in co-cultures, as well as the level of secreted cytokines, were investigated. Our work has revealed a statistically significant dependence of cytofluorymetric results on the presence of TMC or NCC in mixed cellular cultures. Increased expression of CD69(+), CD71(+) and CD25(+) (high), CD26(+), HLA/DR(+) antigens on T CD3(+)CD4(+) and CD3(+)CD8(+) cells was higher in MLTMC cultures, in comparison with MLNCC. We demonstrated negative significant relationships of IFN-γ and IL-10 secretion with regard to CD4(+)CD69(+), CD8(+)CD69(+), CD4(+)CD71(+), CD8(+)CD71(+) antigens expression in 21 h of experiments without mitogenic stimulation. Furthermore, this study revealed negative significant relationships of IFN-g secretion with regard to CD4(+)HLA/DR(+) and CD8(+)HLA/DR(+) as well as between IL-10 concentration and CD4(+)HLA/DR(+) in trials without PHA stimulation. Our findings have confirmed a key role for tumor cells in determining the function of T cells involved in the immunological processes and impact of neoplastic cells on modulating the activity of T CD4(+) and CD8(+) lymphocytes in laryngeal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22252752

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  10 in total

1.  EBV-HLH children with reductions in CD4+ T cells and excessive activation of CD8+ T cells.

Authors:  Cheng Yang; Xiujuan Zhu; Ting Zhang; Qing Ye
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

Review 2.  Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance.

Authors:  Ashwani Sharma; Tarun Virmani; Anjali Sharma; Vaishnavi Chhabra; Girish Kumar; Kamla Pathak; Abdulsalam Alhalmi
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-16       Impact factor: 3.249

Review 3.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

4.  T-Lymphocyte Activation Is Correlated With the Presence of Anti-EBV in Patients With Laryngeal Squamous Cell Carcinoma.

Authors:  Janusz Klatka; Anna Hymos; Anna Szkatuła-Łupina; Ewelina Grywalska; Barbara Klatka; Michał Terpiłowski; Andrzej Stepulak
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

5.  Prognostic Significance of Peripheral T-Cell Subsets in Laryngeal Squamous Cell Carcinoma.

Authors:  Filippo Marchi; Francesco Missale; Fabiola Incandela; Marta Filauro; Francesco Mazzola; Francesco Mora; Alberto Paderno; Giampiero Parrinello; Cesare Piazza; Giorgio Peretti
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-08-28

6.  Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma.

Authors:  Charles R Schutt; Hua Sun; Jaya Sarin Pradhan; Yvonne Saenger; Jessica Ley; Douglas Adkins; Matthew Ingham; Li Ding; Brian A Van Tine
Journal:  Oncotarget       Date:  2021-03-16

7.  Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma.

Authors:  Alice Ko; Victoria S Coward; Nalan Gokgoz; Brendan C Dickson; Kim Tsoi; Jay S Wunder; Irene L Andrulis
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

8.  The Clinical, Pathological, and Prognostic Value of High PD-1 Expression and the Presence of Epstein-Barr Virus Reactivation in Patients with Laryngeal Cancer.

Authors:  Janusz Klatka; Anna Szkatuła-Łupina; Anna Hymos; Maria Klatka; Paulina Mertowska; Sebastian Mertowski; Ewelina Grywalska; Małgorzata Charytanowicz; Anna Błażewicz; Agata Poniewierska-Baran; Dominika Bębnowska; Paulina Niedźwiedzka-Rystwej
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

9.  Optimization of methods for peripheral blood mononuclear cells isolation and expansion of human gamma delta T cells.

Authors:  Mohd Wajid Ali Khan; Ahmed Al Otaibi; Subuhi Sherwani; Eida Mohammed Alshammari; Salma Ahmed Al-Zahrani; Wahid Ali Khan; Abdulmohsen Khalaf Dhahi Alsukaibi; Sultan Alouffi; Shahper Nazeer Khan
Journal:  Bioinformation       Date:  2021-03-31

10.  The role of chemotherapy and operation on lymphocytes accumulation in peripheral blood obtained from patients with oral squamous cell carcinoma.

Authors:  Tao Yu; Ping Guo; Yingying Wu; Jiafeng Zhao; Lichun Wu; Chunhua Li; Kun Liu; Guiquan Zhu; Jin Chen; Chuan Xu; Yongcong Cai; Jifeng Liu; Zhaohui Wang
Journal:  Springerplus       Date:  2015-11-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.